Cardiac Troponin I in Doberman Pinschers with Cardiomyopathy
Autor: | Monia Mahling, Gerhard Wess, Julia Simak, Katrin Hartmann |
---|---|
Rok vydání: | 2010 |
Předmět: |
medicine.medical_specialty
Ventricular premature contraction Cardiac troponin General Veterinary 040301 veterinary sciences business.industry Cardiomyopathy Diagnostic test Dilated cardiomyopathy 04 agricultural and veterinary sciences 030204 cardiovascular system & hematology musculoskeletal system medicine.disease 3. Good health Ventricular premature contractions 0403 veterinary science 03 medical and health sciences 0302 clinical medicine Internal medicine Troponin I cardiovascular system Cardiology Medicine cardiovascular diseases business |
Zdroj: | Journal of Veterinary Internal Medicine. 24:843-849 |
ISSN: | 0891-6640 |
Popis: | Background: Cardiac troponin I (cTnI) is useful for detection of cardiac myocyte damage, but its efficacy in detecting various stages of dilated cardiomyopathy (DCM) in Doberman Pinschers is unclear. Objectives: To evaluate the diagnostic value of cTnI in various stages of DCM in Dobermans. Animals: Six hundred and fifty-three cTnI measurements of 336 Doberman Pinschers. Methods: Using a longitudinal study design, staging of the disease was based upon 24-hour-ambulatory-ECG (Holter) and echocardiography. A total of 447 cTnI measurements were performed in 264 healthy Dobermans, and 206 cTnI measurements in 75 Dobermans with cardiomyopathy. Eighty-eight cTnI samples were from dogs with >100 ventricular premature contractions (VPCs)/24 hour, but without echocardiographic changes (“VPC group”). Additional 19 samples originated from dogs with only echocardiographic changes (“ECHO group”), and 56 samples from dogs with both VPCs and echocardiographic changes (“VPC plus ECHO group”). Twenty samples were from dogs with clinical signs (“clinical group”). The group “incipient” included 23 dogs, that were considered to be normal according to Holter and echocardiography at the time of the exam, but that developed DCM within 1.5 years. Results: cTnI values of dogs in all disease groups, including the “incipient” (0.30 ± 0.20) and “VPC group” (0.36 ± 0.34), were significantly (P= .04, P 0.22 ng/mL had a sensitivity of 79.5% and a specificity of 84.4% to detect all forms of cardiomyopathy. Conclusions and Clinical Importance: cTnI measurement is a valuable diagnostic test that can detect cardiomyopathy in dogs that are otherwise clinically normal. |
Databáze: | OpenAIRE |
Externí odkaz: |